Neuroinflammatory Disorders

Doxycycline was safe and may be effective as adjunctive therapy to antiseizure medication in young people with nodding syndrome, according to research from Lancet Global Health.

Annexon Biosciences has announced positive topline results from a phase 3, randomized placebo-controlled clinical trial examining an investigational monoclonal antibody in those with Guillain-Barré syndrome.